Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 611 JPY 3.34% Market Closed
Market Cap: 39.9B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fuji Pharma Co Ltd
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Selling, General & Administrative
-ÂĄ9.2B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Takeda Pharmaceutical Co Ltd
TSE:4502
Selling, General & Administrative
-ÂĄ1.1T
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Daiichi Sankyo Co Ltd
TSE:4568
Selling, General & Administrative
-ÂĄ696.7B
CAGR 3-Years
-26%
CAGR 5-Years
-20%
CAGR 10-Years
-5%
Otsuka Holdings Co Ltd
TSE:4578
Selling, General & Administrative
-ÂĄ925.7B
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Selling, General & Administrative
-ÂĄ108.4B
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Astellas Pharma Inc
TSE:4503
Selling, General & Administrative
-ÂĄ795.7B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-7%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
39.2B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
1 987.31 JPY
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-9.2B JPY

Based on the financial report for Sep 30, 2024, Fuji Pharma Co Ltd's Selling, General & Administrative amounts to -9.2B JPY.

What is Fuji Pharma Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
0%

Over the last year, the Selling, General & Administrative growth was -11%. The average annual Selling, General & Administrative growth rates for Fuji Pharma Co Ltd have been -3% over the past three years , -1% over the past five years .

Back to Top